Editorial Commentary
Challenges with interpreting pre-operative immunonutrition research
Annals of Esophagus
2026;
9:
9
.
(30 March 2026)
Editorial Commentary
Beyond 5 years after esophagectomy—is cure really achieved?
Annals of Esophagus
2026;
9:
8
.
(30 March 2026)
Editorial Commentary
Second-line chemotherapy in metastatic oesophageal squamous cell carcinoma: has PRODIGE 62-OESIRI closed the door on irinotecan?
Annals of Esophagus
2026;
9:
7
.
(30 March 2026)
Review Article
Neoadjuvant immunochemoradiotherapy in esophageal squamous cell carcinoma: an updated narrative review
Annals of Esophagus
2026;
9:
6
.
(30 March 2026)
Review Article
Esophagitis dissecans superficialis—clinical presentation, diagnosis, and management
Annals of Esophagus
2026;
9:
5
.
(30 March 2026)
Review Article
The role of radiotherapy for the immunotherapy of esophageal squamous cell carcinoma: translational approach and future pathways—a narrative review
Annals of Esophagus
2026;
9:
4
.
(30 March 2026)
Review Article
Management of post-esophagectomy functional disorders: a clinical practice review
Annals of Esophagus
2026;
9:
3
.
(30 March 2026)
Review Article
Sarcopenia in esophageal cancer: causes, clinical implications and future directions—a narrative review
Annals of Esophagus
2026;
9:
2
.
(30 March 2026)
Original Article
Short-term oncological outcomes of hybrid minimally invasive esophagectomy: experience from a regional referral center
Annals of Esophagus
2026;
9:
1
.
(30 March 2026)
